University Of Iowa Hospital & Clinics - Muscatine in Muscatine, Iowa - Dialysis Center

University Of Iowa Hospital & Clinics - Muscatine is a medicare approved dialysis facility center in Muscatine, Iowa and it has 12 dialysis stations. It is located in Muscatine county at 3465 Mulberry Ave, Muscatine, IA, 52761. You can reach out to the office of University Of Iowa Hospital & Clinics - Muscatine at (563) 262-9303. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. University Of Iowa Hospital & Clinics - Muscatine has the following ownership type - Non-Profit. It was first certified by medicare in August, 1996. The medicare id for this facility is 163504 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameUniversity Of Iowa Hospital & Clinics - Muscatine
Location3465 Mulberry Ave, Muscatine, Iowa
No. of Dialysis Stations 12
Medicare ID163504
Managed ByIndependent
Ownership TypeNon-Profit
Late Shifts No

Contact Information


3465 Mulberry Ave, Muscatine, Iowa, 52761
(563) 262-9303

News Archive

Program to help health-carers reduce hospital falls by up to 30%

Researchers at the University of Melbourne have developed a program that could help health-carers reduce by up to 30% the number of falls incurred by patients while in hospital.

Research provides better understanding of workday breaks, debunks common myths

Most people take breaks during their workdays. Coffee breaks. Lunch breaks. Short chats with coworkers. Maybe late afternoon walks around the building.

Agensys, Seattle Genetics to co-develop second antibody-drug conjugate for multiple solid tumors

Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that Seattle Genetics has exercised an option to co-develop a second antibody-drug conjugate (ADC) under the companies' existing ADC collaboration agreement.

Study reveals that most Americans will refuse FDA authorized emergency use H1N1 flu vaccine

A majority of Americans would not take an H1N1 flu vaccine or drug additive authorized for emergency use by the Food and Drug Administration, according to a University of Pittsburgh Graduate School of Public Health and University of Georgia study. The study, available online today in Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, found that fewer than 10 percent of those surveyed said they would be willing to take such a vaccine or drug and nearly 30 percent remained undecided.

Read more Medical News

› Verified 4 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with University Of Iowa Hospital & Clinics - Muscatine from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1972588465
Organization NameUniversity Of Iowa Hospitals & Clinics-muscatine Dialysis Center
Doing Business AsState University Of Iowa
Address3465 Mulberry Ave Muscatine, Iowa, 52761
Phone Number(563) 262-9303

News Archive

Program to help health-carers reduce hospital falls by up to 30%

Researchers at the University of Melbourne have developed a program that could help health-carers reduce by up to 30% the number of falls incurred by patients while in hospital.

Research provides better understanding of workday breaks, debunks common myths

Most people take breaks during their workdays. Coffee breaks. Lunch breaks. Short chats with coworkers. Maybe late afternoon walks around the building.

Agensys, Seattle Genetics to co-develop second antibody-drug conjugate for multiple solid tumors

Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that Seattle Genetics has exercised an option to co-develop a second antibody-drug conjugate (ADC) under the companies' existing ADC collaboration agreement.

Study reveals that most Americans will refuse FDA authorized emergency use H1N1 flu vaccine

A majority of Americans would not take an H1N1 flu vaccine or drug additive authorized for emergency use by the Food and Drug Administration, according to a University of Pittsburgh Graduate School of Public Health and University of Georgia study. The study, available online today in Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, found that fewer than 10 percent of those surveyed said they would be willing to take such a vaccine or drug and nearly 30 percent remained undecided.

Read more Medical News

› Verified 4 days ago


Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data21
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL38

News Archive

Program to help health-carers reduce hospital falls by up to 30%

Researchers at the University of Melbourne have developed a program that could help health-carers reduce by up to 30% the number of falls incurred by patients while in hospital.

Research provides better understanding of workday breaks, debunks common myths

Most people take breaks during their workdays. Coffee breaks. Lunch breaks. Short chats with coworkers. Maybe late afternoon walks around the building.

Agensys, Seattle Genetics to co-develop second antibody-drug conjugate for multiple solid tumors

Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that Seattle Genetics has exercised an option to co-develop a second antibody-drug conjugate (ADC) under the companies' existing ADC collaboration agreement.

Study reveals that most Americans will refuse FDA authorized emergency use H1N1 flu vaccine

A majority of Americans would not take an H1N1 flu vaccine or drug additive authorized for emergency use by the Food and Drug Administration, according to a University of Pittsburgh Graduate School of Public Health and University of Georgia study. The study, available online today in Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, found that fewer than 10 percent of those surveyed said they would be willing to take such a vaccine or drug and nearly 30 percent remained undecided.

Read more Medical News

› Verified 4 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center39
    Adult patient months included in Kt/V greater than or equal to 1.2337
    Percentage of adult patients getting regular hemodialysis at the center99
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Program to help health-carers reduce hospital falls by up to 30%

    Researchers at the University of Melbourne have developed a program that could help health-carers reduce by up to 30% the number of falls incurred by patients while in hospital.

    Research provides better understanding of workday breaks, debunks common myths

    Most people take breaks during their workdays. Coffee breaks. Lunch breaks. Short chats with coworkers. Maybe late afternoon walks around the building.

    Agensys, Seattle Genetics to co-develop second antibody-drug conjugate for multiple solid tumors

    Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that Seattle Genetics has exercised an option to co-develop a second antibody-drug conjugate (ADC) under the companies' existing ADC collaboration agreement.

    Study reveals that most Americans will refuse FDA authorized emergency use H1N1 flu vaccine

    A majority of Americans would not take an H1N1 flu vaccine or drug additive authorized for emergency use by the Food and Drug Administration, according to a University of Pittsburgh Graduate School of Public Health and University of Georgia study. The study, available online today in Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, found that fewer than 10 percent of those surveyed said they would be willing to take such a vaccine or drug and nearly 30 percent remained undecided.

    Read more Medical News

    › Verified 4 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at University Of Iowa Hospital & Clinics - Muscatine with elevated calcium levels.

Patients with hypercalcemia40
Hypercalcemia patient months349
Hypercalcemia patients with serumcalcium greater than 10.2 mg1
Patients with Serumphosphor41
Patients with Serumphosphor less than 3.5 mg/dL9
Patients with Serumphosphor from 3.5 to 4.5 mg/dL27
Patients with Serumphosphor from 4.6 to 5.5 mg/dL27
Patients with Serumphosphor from 5.6 to 7 mg/dL27
Patients with Serumphosphor greater than 7 mg/dL11

News Archive

Program to help health-carers reduce hospital falls by up to 30%

Researchers at the University of Melbourne have developed a program that could help health-carers reduce by up to 30% the number of falls incurred by patients while in hospital.

Research provides better understanding of workday breaks, debunks common myths

Most people take breaks during their workdays. Coffee breaks. Lunch breaks. Short chats with coworkers. Maybe late afternoon walks around the building.

Agensys, Seattle Genetics to co-develop second antibody-drug conjugate for multiple solid tumors

Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that Seattle Genetics has exercised an option to co-develop a second antibody-drug conjugate (ADC) under the companies' existing ADC collaboration agreement.

Study reveals that most Americans will refuse FDA authorized emergency use H1N1 flu vaccine

A majority of Americans would not take an H1N1 flu vaccine or drug additive authorized for emergency use by the Food and Drug Administration, according to a University of Pittsburgh Graduate School of Public Health and University of Georgia study. The study, available online today in Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, found that fewer than 10 percent of those surveyed said they would be willing to take such a vaccine or drug and nearly 30 percent remained undecided.

Read more Medical News

› Verified 4 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 38
Patient months included in arterial venous fistula and catheter summaries 277
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment78
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer8

News Archive

Program to help health-carers reduce hospital falls by up to 30%

Researchers at the University of Melbourne have developed a program that could help health-carers reduce by up to 30% the number of falls incurred by patients while in hospital.

Research provides better understanding of workday breaks, debunks common myths

Most people take breaks during their workdays. Coffee breaks. Lunch breaks. Short chats with coworkers. Maybe late afternoon walks around the building.

Agensys, Seattle Genetics to co-develop second antibody-drug conjugate for multiple solid tumors

Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that Seattle Genetics has exercised an option to co-develop a second antibody-drug conjugate (ADC) under the companies' existing ADC collaboration agreement.

Study reveals that most Americans will refuse FDA authorized emergency use H1N1 flu vaccine

A majority of Americans would not take an H1N1 flu vaccine or drug additive authorized for emergency use by the Food and Drug Administration, according to a University of Pittsburgh Graduate School of Public Health and University of Georgia study. The study, available online today in Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, found that fewer than 10 percent of those surveyed said they would be willing to take such a vaccine or drug and nearly 30 percent remained undecided.

Read more Medical News

› Verified 4 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary33
Hospitalization Rate in facility116.7 (As Expected)
Hospitalization Rate: Upper Confidence Limit265
Hospitalization Rate: Lower Confidence Limit54.8

News Archive

Program to help health-carers reduce hospital falls by up to 30%

Researchers at the University of Melbourne have developed a program that could help health-carers reduce by up to 30% the number of falls incurred by patients while in hospital.

Research provides better understanding of workday breaks, debunks common myths

Most people take breaks during their workdays. Coffee breaks. Lunch breaks. Short chats with coworkers. Maybe late afternoon walks around the building.

Agensys, Seattle Genetics to co-develop second antibody-drug conjugate for multiple solid tumors

Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that Seattle Genetics has exercised an option to co-develop a second antibody-drug conjugate (ADC) under the companies' existing ADC collaboration agreement.

Study reveals that most Americans will refuse FDA authorized emergency use H1N1 flu vaccine

A majority of Americans would not take an H1N1 flu vaccine or drug additive authorized for emergency use by the Food and Drug Administration, according to a University of Pittsburgh Graduate School of Public Health and University of Georgia study. The study, available online today in Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, found that fewer than 10 percent of those surveyed said they would be willing to take such a vaccine or drug and nearly 30 percent remained undecided.

Read more Medical News

› Verified 4 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at University Of Iowa Hospital & Clinics - Muscatine were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility37.9 (As Expected)
Readmission Rate: Upper Confidence Limit55.6
Readmission Rate: Lower Confidence Limit22.8

News Archive

Program to help health-carers reduce hospital falls by up to 30%

Researchers at the University of Melbourne have developed a program that could help health-carers reduce by up to 30% the number of falls incurred by patients while in hospital.

Research provides better understanding of workday breaks, debunks common myths

Most people take breaks during their workdays. Coffee breaks. Lunch breaks. Short chats with coworkers. Maybe late afternoon walks around the building.

Agensys, Seattle Genetics to co-develop second antibody-drug conjugate for multiple solid tumors

Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that Seattle Genetics has exercised an option to co-develop a second antibody-drug conjugate (ADC) under the companies' existing ADC collaboration agreement.

Study reveals that most Americans will refuse FDA authorized emergency use H1N1 flu vaccine

A majority of Americans would not take an H1N1 flu vaccine or drug additive authorized for emergency use by the Food and Drug Administration, according to a University of Pittsburgh Graduate School of Public Health and University of Georgia study. The study, available online today in Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, found that fewer than 10 percent of those surveyed said they would be willing to take such a vaccine or drug and nearly 30 percent remained undecided.

Read more Medical News

› Verified 4 days ago